Protocol for the development and validation procedure of the managing the link and strengthening transition from child to adult mental health care (MILESTONE) suite of measures.
Adult mental health services
Child and adolescent mental health services
Europe
Patient reported outcome measures
Transition
Young persons
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
16 04 2020
16 04 2020
Historique:
received:
12
11
2019
accepted:
13
04
2020
entrez:
18
4
2020
pubmed:
18
4
2020
medline:
1
5
2021
Statut:
epublish
Résumé
Mental health disorders in the child and adolescent population are a pressing public health concern. Despite the high prevalence of psychopathology in this vulnerable population, the transition from Child and Adolescent Mental Health Services (CAMHS) to Adult Mental Health Services (AMHS) has many obstacles such as deficiencies in planning, organisational readiness and policy gaps. All these factors contribute to an inadequate and suboptimal transition process. A suite of measures is required that would allow young people to be assessed in a structured and standardised way to determine the on-going need for care and to improve communication across clinicians at CAMHS and AMHS. This will have the potential to reduce the overall health economic burden and could also improve the quality of life for patients travelling across the transition boundary. The MILESTONE (Managing the Link and Strengthening Transition from Child to Adult Mental Health Care) project aims to address the significant socioeconomic and societal challenge related to the transition process. This protocol paper describes the development of two MILESTONE transition-related measures: The Transition Readiness and Appropriateness Measure (TRAM), designed to be a decision-making aide for clinicians, and the Transition Related Outcome Measure (TROM), for examining the outcome of transition. The TRAM and TROM have been developed and were validated following the US FDA Guidance for Patient-reported Outcome Measures which follows an incremental stepwise framework. The study gathers information from service users, parents, families and mental health care professionals who have experience working with young people undergoing the transition process from eight European countries. There is an urgent need for comprehensive measures that can assess transition across the CAMHS/AMHS boundary. This study protocol describes the process of development of two new transition measures: the TRAM and TROM. The TRAM has the potential to nurture better transitions as the findings can be summarised and provided to clinicians as a clinician-decision making support tool for identifying cases who need to transition and the TROM can be used to examine the outcomes of the transition process. MILESTONE study registration: ISRCTN83240263 Registered 23-July-2015 - ClinicalTrials.gov NCT03013595 Registered 6 January 2017.
Sections du résumé
BACKGROUND
Mental health disorders in the child and adolescent population are a pressing public health concern. Despite the high prevalence of psychopathology in this vulnerable population, the transition from Child and Adolescent Mental Health Services (CAMHS) to Adult Mental Health Services (AMHS) has many obstacles such as deficiencies in planning, organisational readiness and policy gaps. All these factors contribute to an inadequate and suboptimal transition process. A suite of measures is required that would allow young people to be assessed in a structured and standardised way to determine the on-going need for care and to improve communication across clinicians at CAMHS and AMHS. This will have the potential to reduce the overall health economic burden and could also improve the quality of life for patients travelling across the transition boundary. The MILESTONE (Managing the Link and Strengthening Transition from Child to Adult Mental Health Care) project aims to address the significant socioeconomic and societal challenge related to the transition process. This protocol paper describes the development of two MILESTONE transition-related measures: The Transition Readiness and Appropriateness Measure (TRAM), designed to be a decision-making aide for clinicians, and the Transition Related Outcome Measure (TROM), for examining the outcome of transition.
METHODS
The TRAM and TROM have been developed and were validated following the US FDA Guidance for Patient-reported Outcome Measures which follows an incremental stepwise framework. The study gathers information from service users, parents, families and mental health care professionals who have experience working with young people undergoing the transition process from eight European countries.
DISCUSSION
There is an urgent need for comprehensive measures that can assess transition across the CAMHS/AMHS boundary. This study protocol describes the process of development of two new transition measures: the TRAM and TROM. The TRAM has the potential to nurture better transitions as the findings can be summarised and provided to clinicians as a clinician-decision making support tool for identifying cases who need to transition and the TROM can be used to examine the outcomes of the transition process.
TRIAL REGISTRATION
MILESTONE study registration: ISRCTN83240263 Registered 23-July-2015 - ClinicalTrials.gov NCT03013595 Registered 6 January 2017.
Identifiants
pubmed: 32299401
doi: 10.1186/s12887-020-02079-9
pii: 10.1186/s12887-020-02079-9
pmc: PMC7161143
doi:
Banques de données
ISRCTN
['ISRCTN83240263']
ClinicalTrials.gov
['NCT03013595']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
167Subventions
Organisme : FP7 Health
ID : 602442
Pays : International
Références
BMC Health Serv Res. 2013 Jul 03;13:254
pubmed: 23822089
Lancet. 2012 Apr 28;379(9826):1630-40
pubmed: 22538178
J Pediatr Psychol. 2011 Mar;36(2):160-71
pubmed: 20040605
Eur Child Adolesc Psychiatry. 2018 Apr;27(4):501-511
pubmed: 29368253
BMC Health Serv Res. 2008 Jun 23;8:135
pubmed: 18573214
Healthc Q. 2011;14 Spec No 2:32-8
pubmed: 24956424
Ren Fail. 2012;34(6):744-53
pubmed: 22583152
Psychiatr Serv. 2018 Aug 1;69(8):863-870
pubmed: 29759055
Lancet Psychiatry. 2017 Sep;4(9):715-724
pubmed: 28596067
BMJ Open. 2016 Mar 22;6(3):e010693
pubmed: 27006345
Psychiatr Serv. 2012 Mar;63(3):223-9
pubmed: 22307877
BMJ Open. 2017 Oct 16;7(10):e016055
pubmed: 29042376
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Patient Prefer Adherence. 2017 Nov 23;11:1939-1948
pubmed: 29200835
Health Qual Life Outcomes. 2005 Nov 28;3:76
pubmed: 16313678
BMJ Open. 2017 Jun 21;7(6):e015342
pubmed: 28637735
BMC Pediatr. 2014 Jan 09;14:4
pubmed: 24405982
BMC Psychiatry. 2017 Nov 28;17(1):380
pubmed: 29183289
Psychiatr Serv. 2006 Nov;57(11):1594-9
pubmed: 17085607
Clin Child Psychol Psychiatry. 2015 Jul;20(3):436-57
pubmed: 24711585
BMJ Open. 2020 Feb 12;10(2):e035744
pubmed: 32054630
Lancet Psychiatry. 2015 May;2(5):376-378
pubmed: 26360268
J Behav Health Serv Res. 2004 Jul-Sep;31(3):279-96
pubmed: 15263867
J Med Internet Res. 2018 Mar 06;20(3):e79
pubmed: 29510970
Br J Psychiatry Suppl. 2013 Jan;54:s36-40
pubmed: 23288500
Psychiatr Rehabil J. 2018 Dec;41(4):258-265
pubmed: 30507240
J Behav Health Serv Res. 2017 Apr;44(2):316-330
pubmed: 26860728
J Ment Health Policy Econ. 2019 Sep 1;22(3):95-108
pubmed: 31811753
J Health Serv Res Policy. 2014 Apr 3;19(3):169-176
pubmed: 24700210
J Behav Health Serv Res. 2017 Apr;44(2):331-340
pubmed: 26276423
Healthc Manage Forum. 2017 Nov;30(6):283-288
pubmed: 29061073
Br J Psychiatry. 2010 Oct;197(4):305-12
pubmed: 20884954
Br J Psychiatry. 2000 Jul;177:52-8
pubmed: 10945089
J Adolesc Health. 2011 Mar;48(3):295-302
pubmed: 21338902
Ir J Psychol Med. 2015 Mar;32(1):61-69
pubmed: 30185283
J Pediatr Psychol. 2014 Jul;39(6):588-601
pubmed: 24891440
Ment Health Serv Res. 2003 Dec;5(4):209-21
pubmed: 14672500
Int J Qual Health Care. 2008 Oct;20(5):314-23
pubmed: 18635587
BJPsych Bull. 2016 Jun;40(3):142-8
pubmed: 27280035
BMC Health Serv Res. 2017 Apr 20;17(1):293
pubmed: 28424061
Br J Psychiatry. 1999 May;174:413-6
pubmed: 10616607